Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

NewGenIvf (NIVF) Shares Outstanding (Diluted Average) (2022 - 2024)

Historic Shares Outstanding (Diluted Average) for NewGenIvf (NIVF) over the last 3 years, with Q4 2024 value amounting to $743323.0.

  • NewGenIvf's Shares Outstanding (Diluted Average) rose 231676.04% to $743323.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $743323.0, marking a year-over-year increase of 231676.04%. This contributed to the annual value of $743323.0 for FY2024, which is 231676.04% up from last year.
  • Per NewGenIvf's latest filing, its Shares Outstanding (Diluted Average) stood at $743323.0 for Q4 2024, which was up 231676.04% from $30757.0 recorded in Q4 2023.
  • NewGenIvf's Shares Outstanding (Diluted Average)'s 5-year high stood at $743323.0 during Q4 2024, with a 5-year trough of $28797.0 in Q4 2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $30757.0 (2023), whereas its average is $267625.7.
  • In the last 5 years, NewGenIvf's Shares Outstanding (Diluted Average) surged by 680.63% in 2023 and then skyrocketed by 231676.04% in 2024.
  • NewGenIvf's Shares Outstanding (Diluted Average) (Quarter) stood at $28797.0 in 2022, then rose by 6.81% to $30757.0 in 2023, then skyrocketed by 2316.76% to $743323.0 in 2024.
  • Its Shares Outstanding (Diluted Average) stands at $743323.0 for Q4 2024, versus $30757.0 for Q4 2023 and $28797.0 for Q4 2022.